Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Gout, Urate, and Crystal Deposition Disease is Scopus-indexed (Q2, CiteScore 4.2), WoS ESCI. Published by Multidisciplinary Digital Publishing Institute (MDPI).
Checked against the index lists dated .
ISSN 2813-4583Verify ISSN ↗
Publisher: Multidisciplinary Digital Publishing Institute (MDPI)
Cost to publish: About US$1,207 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Medicine (miscellaneous) | 148 / 466 | 68th | Q2 |
| Rheumatology | 30 / 77 | 61st | Q2 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2023–present, best quartile Q2, CiteScore 4.2.
Gout, Urate, and Crystal Deposition Disease is Q2 in Medicine (miscellaneous) (rank 148 of 466) and Q2 in Rheumatology (rank 30 of 77), by CiteScore 2025.
Gout, Urate, and Crystal Deposition Disease is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 4.2, which places it in quartile Q2 at the 68th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.723, quartile Q1, with an H-index of 9.
The publisher lists an article processing charge of about US$1,207 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Gout, Urate, and Crystal Deposition Disease is published by Multidisciplinary Digital Publishing Institute (MDPI). Its ISSN is 2813-4583.
Yes — indexed in the Emerging Sources Citation Index.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Gout, Urate, and Crystal Deposition Disease has an h-index of 11 and a 2-year mean of 3.3 citations per paper (OpenAlex). Its Scopus CiteScore is 4.2, quartile Q2. On 2-year citations it ranks #91 of 451 Scopus journals in Medicine (miscellaneous).
Gout, Urate, and Crystal Deposition Disease published 22 papers in 2025; its busiest recent year was 2024 with 25. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 78 research articles (2022–2026), authors are most often from United States (31.8%), France (10.5%) and New Zealand (10.2%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.